MRKR is trading at $1.59, down 5.4% today on profit-taking and broader market weakness following a sharp 13.5% gain on July 7.
- No fresh company-specific headlines, earnings, or analyst actions have been reported this morning to explain the downward move.
- The stock is underperforming alongside a weaker market, with both the S&P 500 and Nasdaq trading lower on July 8.
- The price action suggests the decline is a result of risk-off sentiment rather than a new fundamental catalyst for Marker Therapeutics.